It’s this inflammation of the lining of your nose that produces the telltale stuffiness sensation of chronic nasal congestion ...

Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and nasal congestion in adults with chronic rhinosinusitis with nasal polyps ...

The companies’ monoclonal antibody met co-primary endpoints in a Phase III trial in patients with chronic rhinosinusitis with ...

November 08, 2024--(BUSINESS WIRE)--Positive high-level results from the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps (CRSwNP ... significant and clinically ...

(IN BRIEF) A Phase III trial of Tezspire (tezepelumab) by AstraZeneca and Amgen has shown significant benefits for patients ...

A phase 3 study has shown that when compared with placebo, Tezspire provided a statistically significant and clinically ...

A deviated septum occurs when you have two different-sized nasal passageways which can cause one-sided congestion.

Complications Associated With Nasal Congestion If left untreated, chronic nasal congestion (nasal congestion that lasts longer than two or three weeks) could be a sign of a more serious conditions ...

often resulting from chronic inflammation. While these benign growths themselves are not harmful, they can lead to ...

Amgen (AMGN) and AstraZeneca's (AZN) asthma therapy Tezspire hits main goals in the Phase 3 trial for chronic rhinosinusitis ...